Cannabis2 years ago
Apollon Formularies Announces Appointment of Dr. Herbert Fritsche, Former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at the University of Texas, MD Anderson Cancer Center in Houston, Texas to the Board of Directors
Apollon Formularies plc (AQSE: APOL) (“Apollon” or the “Company”), a UK based international medical cannabis pharmaceutical company trading on AQSE Growth Market, is pleased to announce the appointment of Dr. Herbert Fritsche to...